P

Prazer Therapeutics

9 employees

Prazer Therapeutics is a biotechnology company that generates novel therapeutics for refractory diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Pharmaceutical
Small Molecule Inhibitor
Therapeutics
Targeted Protein Degradation
Drug Development

Date founded

2019

Funding rounds raised

P

Prazer Therapeutics raised undisclosed on January 1, 2021

Investors: Company K Partners

FAQ